Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient

被引:42
作者
Aksoy, S [1 ]
Abali, H
Kilickap, S
Erman, M
Kars, A
机构
[1] Hacettepe Univ, Inst Oncol, TR-06100 Ankara, Turkey
[2] Ankara Numune Egitim Arastirma Hastanesi, Ankara, Turkey
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2006年 / 28卷 / 03期
关键词
hepatitis C virus; reactivation; rituximab; non-Hodgkin's lymphoma;
D O I
10.1111/j.1365-2257.2006.00779.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The treatment of patients with non-Hodgkin's lymphoma (NHL) may be complicated by concomitant chronic hepatitis C virus (HCV) infection. Recent data suggest that HCV may also be a contributing factor to the development of this disease. Although antiviral treatment has occasionally been reported to result in the regression of lymphoma in patients with HCV infection, the importance of the control of this infection on the prognosis of lymphoma needs to be defined. Here we report a patient with diffuse large B-cell lymphoma who presented with a mass in her left breast. She had had HCV-related liver cirrhosis for 6 years. She was given rituximab monotherapy for three consecutive weeks, but treatment had to be discontinued as a result of hematological toxicity. HCV viral load also increased, but then decreased gradually after rituximab was stopped. She could be given no further therapy. Six months later she presented with spinal involvement with infiltration of the cauda equina. Though cranial-spinal radiotherapy and steroids were started, she died shortly thereafter. Though rituximab is an invaluable drug in the treatment of B-cell lymphomas, we believe that the use of such agents with potentially long-lasting effects on B lymphocytes requires extended vigilance for accelerated replication of hepatitis B and C viruses.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 21 条
[1]  
Bermúdez A, 2000, HAEMATOLOGICA, V85, P894
[2]   Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP [J].
Dai, MS ;
Chao, TY ;
Kao, WY ;
Shyu, RY ;
Liu, TM .
ANNALS OF HEMATOLOGY, 2004, 83 (12) :769-774
[3]   Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab [J].
Hamaki, T ;
Kami, M ;
Kusumi, E ;
Ueyama, J ;
Miyakoshi, S ;
Morinaga, S ;
Mutou, Y .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 68 (04) :292-294
[4]   Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infection [J].
Heider, U ;
Fleissner, C ;
Zavrski, I ;
Jakob, C ;
Dietzel, T ;
Eucker, J ;
Ockenga, J ;
Possinger, K ;
Sezer, O .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (01) :64-66
[5]   Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection [J].
Hermine, O ;
Lefrère, F ;
Bronowicki, JP ;
Mariette, X ;
Jondeau, K ;
Eclache-Saudreau, V ;
Delmas, B ;
Valensi, F ;
Cacoub, P ;
Brechot, C ;
Varet, B ;
Troussard, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (02) :89-94
[6]   Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy [J].
Isobe, Y ;
Sugimoto, K ;
Shiraki, Y ;
Nishitani, M ;
Koike, K ;
Oshimi, K .
AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (04) :370-373
[7]  
Mazzaro C, 1997, ITAL J GASTROENTEROL, V29, P343
[8]  
Mazzaro C, 1996, CANCER, V77, P2604, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO
[9]  
2-V
[10]   Inappropriate antidiuretic hormone secretion, abdominal pain and disseminated varicella-zoster virus infection: an unusual and fatal triad in a patient 13 months post Rituximab and autologous stem cell transplantation [J].
McIlwaine, LM ;
Fitzsimons, EJ ;
Soutar, RL .
CLINICAL AND LABORATORY HAEMATOLOGY, 2001, 23 (04) :253-254